Market Overview

Citi Reiterates Buy on Eli Lilly and Company, Maintains $55.00 PT

Share:

Latest Ratings for LLY

DateFirmActionFromTo
Apr 2017Argus ResearchDowngradesBuyHold
Apr 2017BMO CapitalDowngradesMarket PerformUnderperform
Apr 2017Morgan StanleyDowngradesOverweightEqual-Weight

View More Analyst Ratings for LLY
View the Latest Analyst Ratings

Posted-In: News Reiteration Analyst Ratings

 

Related Articles (LLY)